Innovative Diagnostic Laboratory has launched the Find10Early™ campaign. We’re encouraging healthcare professionals to identify at least 10 of your patients at high-risk for lung cancer, and to perform EarlyCDT-Lung blood tests to help stratify their risk for developing lung cancer. The key advantage of EarlyCDT-Lung is its ability to help detect lung cancer at its earliest possible stages, when treatment can be most successful. EarlyCDT-Lung can help detect risk of lung cancer up to 5 years earlier than low-dose CT scan.3,4,5,7
What Identifies a Patient as High Risk for Development of Lung Cancer?
Age 50-75 smoker/ex-smoker > 20 pack-year* history
Age 45-49 smoker/ex-smoker 25-45 pack-year history and 2 additional risk factors (see below)
Age 45-49 smoker/ex-smoker with > 45 pack-year history and one additional risk factor (see below)
Age 40-44 smoker/ex-smoker with > 45 pack-year history and two additional risk factors
Patients with indeterminate pulmonary nodules
Additional risk factors include:
Family history of lung disease
Emphysema or chronic obstructive pulmonary disease (COPD)
Environmental exposures (radon, asbestos, coal products, radioactive substances)
* A Pack-Year is the number of packs smoked per day multiplied by the number of years smoked.
EarlyCDT-Lung results have been published in several peer reviewed journals (cited at bottom of page) including the Journal of Lung Cancer.